|
Placebo of HM15275 Clinical Trials
1 actively recruiting trial across 1 location
No change since March 2026
Pipeline
Phase 2: 1
Top Sponsors
- Hanmi Pharmaceutical Company Limited1
Indications
- T2DM1
- Type 2 Diabetes Mellitus1
- Diabetes1
Glendale, Arizona1 trial
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Lenzmeier Family Medicine
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.